Retrospective analysis of impact of automated insulin delivery technology on acute care utilisation from 2019 to 2021
Use of AID systems among PwT1D was associated with lower odds of IP and ED utilisation and lower costs in the follow-up period compared to MDI.
Authors
- Kevin J. Lavelle
- Anders L. Carlson (ORCID: https://orcid.org/0000-0002-5738-2818)
- Viral N. Shah (ORCID: https://orcid.org/0000-0002-3827-7107)
- Diana I Brixner (ORCID: https://orcid.org/0000-0001-6637-6359)
- Neel Vaidya (ORCID: https://orcid.org/0000-0002-5697-5881)
- Laurel H. Messer (ORCID: https://orcid.org/0000-0001-7493-0989)
- Janna Manjelievskaia (ORCID: https://orcid.org/0000-0002-8293-512X)
- Jordan E. Pinsker (ORCID: https://orcid.org/0000-0003-4080-9034)
- Daniel C. Malone (ORCID: https://orcid.org/0000-0002-5006-9394)
- Susan M. Wall (ORCID: https://orcid.org/0000-0003-2786-8849)
- Sharon M. Wang
- Bimal V. Patel (ORCID: https://orcid.org/0000-0003-4453-3303)
- Diana Isaacs
- Kimberly W. McDermott
- Charles A. Stemple
Institutions
- Cleveland Clinic (US)
- University of Utah (US)
- Tandem Diabetes Care (United States) (US)
- RED Consulting (Norway) (NO)
- Diagnostics for the Real World (United States) (US)
- Indiana University School of Medicine
- HealthPartners (US)
- Indiana University – Purdue University Indianapolis (US)
- University of Montana (US)
Publication Details
- Journal
- Diabetic Medicine
- Published
- 2025-10-04
- DOI
- https://doi.org/10.1111/dme.70147
- Primary Topic
- Diabetes Management and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Sanofi
- Insulet Corporation
- Dexcom